Combined effects of soy isoflavone and fish oil on ovariectomy-induced bone loss in mice

Journal of Bone and Mineral Metabolism

Volumn 29, Issue 4, 2011, Pages 404-413

  Uchida, Raina ^a   Chiba, Hiroshige ^a   Ishimi, Yoshiko ^b   Uehara, Mariko ^c   Suzuki, Kazuharu ^c   Kim, Hyounju ^a   Matsumoto, Akiyo ^a  

^a JOSAI UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF HEALTH AND NUTRITION   (Japan)

^c TOKYO UNIVERSITY OF AGRICULTURE   (Japan)

Author keywords

Bone resorbing cytokines; Flavonoid; Osteoporosis; Polyunsaturated fatty acids

Indexed keywords

CALCIUM; COLLAGEN TYPE 1; DAIDZEIN; EQUOL; FISH OIL; GENISTEIN; INTERLEUKIN 1; ISOFLAVONE; OSTEOCALCIN; PROSTAGLANDIN E2; SAFFLOWER OIL; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE CHARACTERISTICS AND FUNCTIONS; BONE DENSITY; BONE VOLUME; CALCIUM BONE LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; FEMALE; FEMUR; HISTOLOGY; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; OSTEOMETRY; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; PROSTAGLANDIN BLOOD LEVEL; PROTEIN BLOOD LEVEL; THERAPY EFFECT; TRABECULAR BONE; TRABECULAR THICKNESS;

ANIMALS; BIOLOGICAL MARKERS; BODY WEIGHT; BONE DENSITY; BONE RESORPTION; CALCIUM; DIET; DRUG THERAPY, COMBINATION; FEEDING BEHAVIOR; FEMALE; FEMUR; FISH OILS; ISOFLAVONES; MICE; MICE, INBRED C57BL; ORGAN SIZE; OVARIECTOMY; SAFFLOWER OIL; SOYBEANS; UTERUS;

EID: 80052515064     PISSN: 09148779     EISSN: 14355604     Source Type: Journal    
DOI: 10.1007/s00774-010-0234-8     Document Type: Article

References (50)

1. Fujiwara S (2005) Epidemiology of osteoporosis in Japan. J Bone Miner Metab 23S:81-83
2. Fujiwara S, Kasagi F, Masunari N, Naito K, Suzuki G, Fukunaga M (2003) Fracture prediction from bone mineral density in Japanese men and women. J Bone Miner Res 18:1547-1553 (Pubitemid 41070810)
3. Hagino H, Yamamoto K, Ohshiro H, Nakamura T, Kishimoto H, Nose T (1999) Changing incidence of hip, distal radius, and proximal humerus fracture in Tottori prefecture. Jpn Bone 24:265-270 (Pubitemid 29094571)
4. Adlercreutz H, Mazur W (1997) Phyto-oestrogens and Western diseases. Ann Med 29:95-120 (Pubitemid 27226319)
5. Somekawa Y, Chiguchi M, Ishibashi T, Aso T (2001) Soy intake related to menopausal symptoms, serum lipids, and bone mineral density in postmenopausal Japanese women. Obstet Gynecol 97:109-115 (Pubitemid 32057167)
6. Zhang X, Shu XO, Li H, Yang G, Li Q, Gao YT, Zheng W (2005) Prospective cohort study of soy food consumption and risk of bone fracture among postmenopausal women. Arch Intern Med 165:1890-1895 (Pubitemid 41352084)
7. Morabito N, Crisafulli A, Vergara C, Gaudio A, Lasco A, Frisina N, D'Anna R, Corrado F, Pizzoleo MA, Cincotta M, Altavilla D, Ientile R, Squadrito F (2002) Effects of genistein and hormonereplacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study. J Bone Miner Res 17:1904-1912
8. Messina MJ (2002) Soy foods and soybean isoflavones and menopausal health. Nutr Clin Care 5:272-282
9. Ma DF, Qin LQ, Wang PY, Katoh R (2008) Soy isoflavone intake increases bone mineral density in the spine of menopausal women: meta-analysis of randomized controlled trials. Clin Nutr 27:57-64
10. Kreijkamp-Kaspers S, Kok L, Grobbee DE, de Haan EH, Aleman A, Lampe JW, van der Schouw YT (2004) Effect of soy protein containing isoflavones on cognitive function, bone mineral density, and plasma lipids in postmenopausal women: a randomized controlled trial. JAMA 292:65-74 (Pubitemid 38923795)
11. Roughead ZK, Hunt JR, Johnson LK, Badger TM, Lykken GI (2005) Controlled substitution of soy protein for meat protein: effects on calcium retention, bone, and cardiovascular health indices in postmenopausal women. J Clin Endocrinol Metab 90:181-189 (Pubitemid 40116654)
12. Cheong JM, Martin BR, Jackson GS, Elmore D, McCabe GP, Nolan JR, Barnes S, Peacock M, Weaver CM (2007) Soy isoflavones do not affect bone resorption in postmenopausal women: a dose-response study using a novel approach with 41Ca. J Clin Endocrinol Metab 92:577-582
13. Brink E, Coxam V, Robins S, Wahala K, Cassidy A, Branca F, PHYTOS Investigators (2008) Long-term consumption of isoflavone- enriched foods does not affect bone mineral density, bone metabolism, or hormonal status in early postmenopausal women: a randomized, double-blind, placebo controlled study. Am J Clin Nutr 87:761-770 (Pubitemid 351364559)
14. Darling AL, Millward DJ, Torgerson DJ, Hewitt CE, Lanham- New SA (2009) Dietary protein and bone health: a systematic review and meta-analysis. Am J Clin Nutr 90:1674-1692
15. Alekel DL, Van Loan MD, Koehler KJ, Hanson LN, Stewart JW, Hanson KB, Kurzer MS, Peterson CT (2010) The soy isoflavones for reducing bone loss (SIRBL) study: a 3-year randomized controlled trial in postmenopausal women. Am J Clin Nutr 91:218-230
16. Calder PC (1997) n-3 polyunsaturated fatty acids and cytokine production in health and disease. Ann Nutr Metab 41:203-234 (Pubitemid 27472618)
17. Simopoulos AP (2002) Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr 21:495-505 (Pubitemid 36026261)
18. James MJ, Gibson RA, Cleland LG (2000) Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Clin Nutr 71:343S-348S (Pubitemid 30046139)
19. Boyle WJ (2003) Osteoclast differentiation and activation. Nature 423:337-342 (Pubitemid 40852708)
20. Watkins BA, Li Y, Allen KG, Hoffmann WE, Seifert MF (2000) Dietary ratio of (n-6)/(n-3) polyunsaturated fatty acids alters the fatty acid composition of bone compartments and biomarkers of bone formation in rats. J Nutr 130:2274-2284
21. Sun D, Krishnan A, Zaman K, Lawrence R, Bhattacharya A, Fernandes G (2003) Dietary n-3 fatty acids decrease osteoclastogenesis and loss of bone mass in ovariectomized mice. J Bone Miner Res 18:1206-1216 (Pubitemid 37294913)
22. Ward WE, Fonseca D (2007) Soy isoflavones and fatty acids: effects on bone tissue postoovariectomy in mice. Mol Nutr Food Res 51:824-831 (Pubitemid 47173692)
23. Watkins BA, Li Y, Lippman HE, Seifert MF (2005) Protective actions of soy isoflavones and n-3 PUFAs on bone mass in ovariectomized rats. J Nutr Biochem 16:479-488 (Pubitemid 41039222)
24. Ohta A, Uehara M, Sakai K, Takasaki M, Adlercreutz H, Morohashi T, Ishimi Y (2002) A combination of dietary fructooligosaccharides and isoflavone conjugates increases femoral bone mineral density and equol production in ovariectomized mice. J Nutr 132:2048-2054 (Pubitemid 34742898)
25. Hidaka S, Okamoto Y, Niyazaki K, Uesugi T (2003) Evaluation of a soybean product fujiflavone P40 as an antiosteoporotic agent in rats. Phytother Res 17:112-119 (Pubitemid 36262257)
26. Uesugi T, Toda T, Tsuji K, Ishida H (2001) Comparative study on reduction of bone loss and lipid metabolism abnormality in ovariectomized rats by soy isoflavones, daidzin, genistin, and glycitin. Biol Pharm Bull 24:368-372 (Pubitemid 32380995)
27. Picherit C, Bennetau-Pelissero C, Chanteranne B, Lebecque P, Davicco MJ, Barlet JP, Coxam V (2001) Soybean isoflavones dose-dependently reduce bone turnover but do not reverse established osteopenia in adult ovariectomized rats. J Nutr 131:723-728 (Pubitemid 32199136)
28. Reeves PG, Nielsen FH, Fahey GC Jr (1993) AIN-93G purified diets for laboratory rodents: final report of American Institute of Nutrition ad hoc writing committee on reformulation of the AIN-76A rodent diet. J Nutr 123:1939-1951 (Pubitemid 23342492)
29. Gimblet EG, Marney AF, Bonsnes RW (1967) Determination of calcium and magnesium in serum, urine, diet and stool by atomic absorption spectrophotometry. Clin Chem 13:204-214
30. Wang GJ, Lapcík O, Hampl R, Uehara M, Al-Maharik N, Stumpf K, Mikola H, Wähälä K, Adlercreutz H (2000) Time-resolved fluoroimmunoassay of plasma daidzein and genistein. Steroids 65:339-348 (Pubitemid 30236340)
31. Brouwers E, L'homme R, Al-Maharik N, Lapcik O, Hampl R, Wähälä K, Mikola H, Adlercreutz H (2003) Time-resolved fluoroimmunoassay for equol in plasma and urine. J Steroid Biochem Mol Biol 84:577-588 (Pubitemid 36588811)
32. Yamanouchi K, Yada E, Hozumi H, Ueno C, Nishihara M (2004) Analyses of hind leg skeletons in human growth hormone transgenic rats. Exp Gerontol 39:1179-1188 (Pubitemid 39024367)
33. Ishida H, Uesugi T, Hirai K, Toda T, Nukaya H, Yokotsuka K, Tsuji K (1998) Preventive effects of the plant isoflavones, daidzin and genistin, on bone loss in ovariectomized rats fed a calciumdeficient diet. Biol Pharm Bull 21:62-66 (Pubitemid 28087819)
34. Kanno J, Onyon L, Peddada S, Ashby J, Jacob E, Owens W (2003) The OECD program to validate the rat uterotrophic bioassay. Phase 2: dose-response studies. Environ Health Perspect 111:1530-1549 (Pubitemid 37120834)
35. Ishimi Y, Arai N, Wang X, Wu J, Umegaki K, Miyaura C, Takeda A, Ikegami S (2000) Difference in effective dosage of genistein on bone and uterus in ovariectomized mice. Biochem Biophys Res Commun 274:697-701 (Pubitemid 30663681)
36. Kruger MC, Claassen N, Smuts CM, Potgieter HC (1997) Correlation between essential fatty acids and parameters of bone formation and degradation. Asia Pacific J Clin Nutr 6:235-238
37. Sirois I, Cheung AM, Ward WE (2003) Biomechanical bone strength and bone mass in young male and female rats fed a fish oil diet. Prostaglandins Leukot Essent Fatty Acids 68:415-421 (Pubitemid 36724033)
38. Trebble TM (2005) Bone turnover and nutritional status in Crohn's disease: relationship to circulating mononuclear cell function and response to fish oil and antioxidants. Proc Nutr Soc 64:183-191 (Pubitemid 40813540)
39. Watkins BA, Li Y, Lippman HE, Feng S (2003) Modulatory effect of omega-3 polyunsaturated fatty acids on osteoblast function and bone metabolism. Prostaglandins Leukot Essent Fatty Acids 68:387-398 (Pubitemid 36724030)
40. Claassen N, Coetzer H, Steinmann CM, Kruger MC (1995) The effect of different n-6/n-3 essential fatty acid ratios on calcium balance and bone in rats. Prostaglandins Leukot Essent Fatty Acids 53:13-19
41. Haag M, Magada ON, Claassen N, Bohmer LH, Kruger MC (2003) Omega-3 fatty acids modulate ATPases involved in duodenal Ca absorption. Prostaglandins Leukot Essent Fatty Acids 68:423-429 (Pubitemid 36724034)
42. Schlemmer CK, Coetzer H, Claassen N, Kruger MC (1999) Oestrogen and essential fatty acid supplementation corrects bone loss due to ovariectomy in the female Sprague-Dawley rat. Prostaglandins Leukot Essent Fatty Acids 61:381-390
43. Watkins BA, Li Y, Lippman HE, Seifert MF (2001) Omega-3 polyunsaturated fatty acids and skeletal health. Exp Biol Med (Maywood) 226:485-497 (Pubitemid 32524495)
44. Weiler HA, Fitzpatrick-Wong SC (2002) Modulation of essential (n-6):(n-3) fatty acid ratios alters fatty acid status but not bone mass in piglets. J Nutr 132:2667-2672 (Pubitemid 35013252)
45. Hill PA (1998) Bone remodelling. Br J Orthod 25:101-107
46. Fleish H, Neuman WF (1961) Mechanisms of calcification: role of collagen, polyphosphates, and phosphate. Am J Physiol 200:1296-1300
47. Hunter GK, Goldberg HA (1993) Nucleation of hydroxyapatite by bone sialoprotein. Proc Natl Acad Sci USA 90:8562-8565 (Pubitemid 23277709)
48. Parfitt AM (1990) Osteomalacia and related disorders. In: Aviloi LV, Krane SM (eds) Metabolic bone disease and clinically related disorders. WB Saunders, Philadelphia, pp 329-396
49. Rowland IR, Wiseman H, Sanders TA, Adlercreutz H, Bowey EA (2000) Interindividual variation in metabolism of soy isoflavones and lignans: influence of habitual diet on equol production by the gut microflora. Nutr Cancer 36:27-32 (Pubitemid 30317832)
50. Fujioka M, Uehara M, Wu J, Adlercreutz H, Suzuki K, Kanazawa K, Takeda K, Yamada K, Ishimi Y (2004) Equol, a metabolite of daidzein, inhibits bone loss in ovariectomized mice. J Nutr 134:2623-2627 (Pubitemid 39315263)